What’s New? What’s Best? Dry Eye Drops, Demodex, MGD, DEWSIII Update & More!
Date: 15/07/2025 ()
Venue: https://cvent.me/MMn33L, AUSTRALIA
Provider: Cornea & Contact Lens Society of Australia
Contact: CORP COMM, [E] info@corpcomm.com.au, [P] 03 5977 0244
Activity Outline
What’s New? What’s Best?
Dry Eye Drops, Demodex, MGD, DEWSIII Update & More!
Picking the Best Options for Patients
New Dry Eye Management Options
Long-Term Management
Managing expectations
Ethics & Economics
Sponsor Presentations
Panel, Q&A & Discussion
Cornea and Contact Lens Society of Australia (CCLSA)
Tuesday 15th JULY 2025
7:30PM to 9:00PM AEST
Learning Objectives
- Understand how DEWS III has changed how we understand and look at dry eye from DEWS II
- Understand the evolving pathophysiology of dry eye - with a first time look at neurosensory dysregulation and its role in dry eye.
- Identify the types of dry eye and identify which patients may benefit from an eye drop that supports multiple layers of the tear film
- Describe the unique mechanism of action of novel new moisturising drops to enter the Australian market such as ROHTO Dry Aid, and clinical indications and its role in symptom modulation and its potential place in a prescribing hierarchy for prescribing for dry eye
- Understand the core values and missions of ROHTO and know of upcoming products
- Understand options to control or eliminate Demodex and understand what does not eliminate Demodex
- Understand the benefits of clean eyelids and lashes
- Understand that providing options to patients is critical and recognise the available options
- Apply clinical reasoning through real-world case discussions involving ROHTO
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Not Just another Dry Eye Drop! |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Sponsor Message |
| Clinical? |
| No |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.25 |
| Name |
|---|
| Best Strategies for Managing Demodex and Blepharitis. |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Panel Q&A |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.25 |